The age of targeted cancer therapies brings the potential for more treatment options, greater effectiveness and fewer side ...

IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC Holdings” or the “Company”) has launched Ignite Proteomics LLC (“Ignite”), its new ...

Research co-led by University of Toronto researchers and Insilico Medicine has demonstrated the potential of quantum ...

Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefited from first-line treatment with the ...

Researchers have discovered how a particular protein affects the growth and spread of colon cancer in humans. The study not ...

Aspirin use in patients with PI3K-mutated colorectal cancer helped to reduce disease recurrence, highlighting the importance ...

We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...

Clatterbridge patients will soon be able to join a pioneering cancer vaccine clinical research trial aimed at finding a ...

Tempus AI’s diagnostic platform drives growth, but US healthcare reimbursement remains a hurdle. Learn why TEM stock is worth ...

A new review was published in Oncotarget's Volume 16 on January 20, 2025, titled "Evolving concepts in HER2-low breast cancer: Genomic insights, definitions, and treatment paradigms." ...